Skip to content
10-Q

Quarterly Report

Nexvet Biopharma plc

0001564590-17-001347

← back to feed
Filed
Feb 10, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jan 31, 2017 11.75M sh
Cash And Equivalents Q2 2017 · Dec 31, 2016 $20.48M
Cash And Equivalents Q2 2017 · Jun 30, 2016 $31.48M
Cash And Equivalents Q2 2017 · Dec 31, 2015 $43.08M
Cash And Equivalents Q2 2017 · Jun 30, 2015 $52.03M
Stockholders Equity Q2 2017 · Dec 31, 2016 $26.09M
Stockholders Equity Q2 2017 · Jun 30, 2016 $35.14M
Stockholders Equity Q2 2017 · Jun 30, 2015 $53.58M
Current Liabilities Q2 2017 · Dec 31, 2016 $2.83M
Current Liabilities Q2 2017 · Jun 30, 2016 $5.05M
Total Liabilities Q2 2017 · Dec 31, 2016 $2.92M
Total Liabilities Q2 2017 · Jun 30, 2016 $5.19M
Current Assets Q2 2017 · Dec 31, 2016 $23.19M
Current Assets Q2 2017 · Jun 30, 2016 $34.96M
Total Assets Q2 2017 · Dec 31, 2016 $29.01M
Total Assets Q2 2017 · Jun 30, 2016 $40.32M
Sga Expense Q2 2017 · Dec 31, 2016 $1.41M
Sga Expense Q2 2017 · Dec 31, 2016 $3.64M
Sga Expense Q2 2017 · Dec 31, 2015 $1.78M
Sga Expense Q2 2017 · Dec 31, 2015 $3.65M
Rd Expense Q2 2017 · Dec 31, 2016 $3.75M
Rd Expense Q2 2017 · Dec 31, 2016 $7.22M
Rd Expense Q2 2017 · Dec 31, 2015 $3.79M
Rd Expense Q2 2017 · Dec 31, 2015 $7.52M
Net Income Q2 2017 · Dec 31, 2016 −$5.41M
Net Income Q2 2017 · Dec 31, 2016 −$10.51M
Net Income Q2 2017 · Jun 30, 2016 −$19.37M
Net Income Q2 2017 · Dec 31, 2015 −$5.69M
Net Income Q2 2017 · Dec 31, 2015 −$9.65M
Operating Income Q2 2017 · Dec 31, 2016 −$5.16M
Operating Income Q2 2017 · Dec 31, 2016 −$10.86M
Operating Income Q2 2017 · Dec 31, 2015 −$5.57M
Operating Income Q2 2017 · Dec 31, 2015 −$11.16M
Capex Q2 2017 · Sep 30, 2015 $1.89M